HMD invests over USD 15M to ramp up syringe production for COVID-19 vaccination

Hindustan Syringes & Medical Devices (HMD) invested over USD 15 million (approx. ₹100 crore) from its own resources in May 2020 to mass produce specialty syringes for COVID-19 vaccination, followed by a second round of over ₹100 crore in 2021-22.

“HMD initiated in May 2020 an investment of over USD 15 million (approx. ₹100 crore) from their own resources, without government support to mass produce specialty syringes even before purchase orders were in sight.”medicalbuyer.co.in

• 1 source
• medicalbuyer.co.inCelebrating 65 years of success - Medical BuyerMay 2022May 10, 2022

Summarized from public sources; check the original articles before acting on it.